Early diarrhoea under sorafenib as a marker to consider the early migration to second-line drugs.
Díaz-González Á, Sapena V, Boix L, Torres F, Sanduzzi-Zamparelli M, Da Fonseca LG, LLarch N, Iserte G, Guedes C, Muñoz-Martínez S, Darnell A, Belmonte E, Rimola J, Forner A, Ayuso C, Bruix J, Reig M.
Díaz-González Á, et al.
United European Gastroenterol J. 2021 Jul;9(6):655-661. doi: 10.1002/ueg2.12111. Epub 2021 Jul 6.
United European Gastroenterol J. 2021.
PMID: 34228394
Free PMC article.